Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06029270
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-09-07
Brief Title:
Testing the Addition of BMS-986016 Relatlimab to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
Sponsor:
Organization:
National Cancer Institute NCI